Chronic Use of Proton Pump Inhibitors Is Associated With Reduced 30‐Day Mortality From Acute Pancreatitis
Authors:
- 31 January 2025
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 61 (8) , 1387-1390
Abstract
Proton pump inhibitors (PPIs) decrease pancreatic exocrine secretions. There has been interest in the impact of their short‐term in‐hospital administration on acute pancreatitis (AP) outcomes. It is unknown whether long‐term use affects AP outcomes. We investigated the association between chronic PPI use and short‐term AP outcomes. We included all (2308) patients admitted with a primary diagnosis of AP (625 on chronic PPI use) between January 2008 and June 2021 and evaluated any association between chronic PPI use and 30‐day all‐cause mortality by univariate logistic regression. Compared to non‐users, patients on chronic PPIs were older (p < 0.001) and had a higher Charlson Comorbidity Index score (p < 0.001). Mortality rates at 30 days were 1.6% in chronic PPI users and 4.4% in non‐users (OR 0.35; 95% CI, 0.17–0.66; p < 0.002). [Correction added on 18 February 2025, after first online publication: Mortality rates at 30 days in chronic PPI users and non‐users were updated in this version.]Keywords
This publication has 9 references indexed in Scilit:
- Use of proton pump inhibitors improves outcomes in mild acute pancreatitis: A nationwide cohort studyMedicine, 2024
- No evidence for the benefit of PPIs in the treatment of acute pancreatitis: a systematic review and meta-analysisScientific Reports, 2023
- Proton Pump Inhibitors Were Associated With Reduced Pseudocysts in Acute Pancreatitis: A Multicenter Cohort StudyFrontiers in Pharmacology, 2021
- Advantages and Disadvantages of Long-term Proton Pump Inhibitor UseJournal of Neurogastroenterology and Motility, 2018
- Effects of proton pump inhibitor on outcomes of patients with severe acute pancreatitis based on a national administrative databasePancreatology, 2015
- Proton Pump Inhibitors Inhibit Pancreatic Secretion: Role of Gastric and Non-Gastric H+/K+-ATPasesPLOS ONE, 2015
- Effects of Pantoprazole in experimental acute pancreatitisLife Sciences, 2010
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- Prognostic factors in acute pancreatitis.Gut, 1984